Australian Capital Markets Stock News

Vysarn (ASX:VYS) has put up another solid reporting period, with H1 2026 results framed by trailing 12 month revenue of about A$132.3 million, net income of roughly A$14.4 million and basic EPS of A$0.027213. The company has seen revenue move from A$37.0 million in H2 2024 to A$41.0 million in H1 2025 and then A$65.5 million in H2 2025, while basic EPS over those halves stepped from A$0.009416 to A$0.0075 and then A$0.013513, setting up the current trailing profile. With net profit margins...

PlaySide Studios reported half-year results to 31 December 2025, with sales of A$20.41 million and net income of A$7.94 million, reversing the prior period’s loss. Despite lower sales than a year earlier, the swing from a basic loss per share of A$0.013 to earnings of A$0.0179 highlights a marked turnaround in profitability and cost control. With PlaySide’s shift from a net loss to profit now on record, we’ll explore how this earnings turnaround reshapes its investment narrative. We've...

Symal Group (ASX:SYL) has drawn fresh attention after releasing half year results to 31 December 2025, reporting A$499.38 million in sales, A$504.2 million in revenue, and A$19.29 million in net income. See our latest analysis for Symal Group. Despite the strong half year earnings update, Symal Group’s recent share price performance has been weak, with a 7 day share price return showing a 23.25% decline and a year to date share price return showing a 30.55% decline from A$2.41, while its 1...

Aeris Resources (ASX:AIS) has reported a cleaner set of numbers for H1 2026, supported by trailing 12 month revenue of A$590.6 million and basic EPS of A$0.06. This follows H2 2025 figures that showed revenue of A$284.3 million and basic EPS of A$0.02. The company’s revenue moved from A$253.7 million and basic EPS of A$0.01 in H2 2024 to A$292.7 million and basic EPS of A$0.03 in H1 2025, before coming in at A$284.3 million and basic EPS of A$0.02 in H2 2025, while trailing 12 month net...

Emerald Resources (ASX:EMR) has released its H1 2026 scorecard, with investors examining how the latest half compares with a recent run that included H2 2025 revenue of A$198.1 million and basic EPS of A$0.042, as well as H1 2025 revenue of A$240.0 million and basic EPS of A$0.0909. Over the trailing twelve months, the company has reported revenue moving from A$434.4 million to A$455.2 million and basic EPS shifting from A$0.1559 to A$0.1534, providing a fuller picture of how the current...

If you are wondering whether Wesfarmers at around A$81.09 is offering fair value or asking too much, this article walks through what the current price might be telling you. The share price has pulled back with an 8.9% decline over the last 7 days and is slightly lower over 30 days and year to date. It still sits on a 13.9% 1 year return and 86.5% and 97.0% over 3 and 5 years respectively. Recent attention on Wesfarmers has focused on its position as a major Australian conglomerate with...

IPD Group (ASX:IPG) has put out its H1 2026 scorecard, with revenue of A$192.7 million and basic EPS of A$0.135. Trailing twelve month figures sit at A$370.4 million of revenue and EPS of A$0.259. The company has seen revenue move from A$176.9 million in H1 2025 to A$192.7 million in H1 2026, with basic EPS stepping from A$0.129 to A$0.135 over the same halves. This sets up a story where modest earnings growth meets a trailing net profit margin that has softened slightly. For investors, the...

Praemium (ASX:PPS) has put fresh numbers on the table for H1 2026, reporting total revenue of A$51.66 million and basic EPS of A$0.016. This comes against a backdrop of trailing 12 month revenue of A$108.75 million and EPS of A$0.037. The company has seen revenue move from A$44.20 million and EPS of A$0.0098 in H2 2024 to A$51.38 million and A$0.012 in H1 2025, before reaching A$51.66 million and A$0.016 in H2 2025. This sets up the latest result against a year where earnings grew 66.7% and...

Austal (ASX:ASB) has reported new figures for H1 2026, with revenue of A$997.6 million and basic EPS of A$0.16, alongside net income of A$64.6 million. The company’s revenue has moved from A$751.3 million and EPS of A$0.01 in H1 2024 to A$825.7 million and A$0.07 in H1 2025, then to A$997.6 million and A$0.16 in H2 2025. This contributes to trailing 12 month net income of A$95.1 million on A$2.1 billion of revenue. For investors, the central question is how sustainable these margins appear as...

G8 Education (ASX:GEM) has wrapped up FY 2025 with second half revenue of A$482.2 million and basic EPS of A$0.43 loss, while the trailing twelve months show revenue of A$946.8 million and basic EPS of A$0.39 loss. The company has seen revenue move from A$534.7 million in the second half of 2024 to A$482.2 million in the second half of 2025, with EPS shifting from A$0.06 to A$0.43 loss over the same period. This sets up a story where investors are weighing revenue scale against pressure on...

Stanmore Resources (ASX:SMR) has released its FY 2025 numbers with second half revenue of US$1,015.8 million, basic EPS of US$0.00366 and net income of US$3.3 million. The trailing twelve month figures show revenue of US$1,883 million, a loss of US$47.2 million and basic EPS of US$0.052363. Over the past few reporting periods, revenue has moved from US$2,396.7 million with EPS of US$0.212449 in the second half of FY 2024 to US$867.2 million with EPS of US$0.056024 in the first half of FY...

PYC Therapeutics (ASX:PYC) has reported its H1 2026 numbers with trailing twelve month revenue of A$21.8 million and a basic EPS loss of A$0.085, indicating that the business is still investing heavily to progress its pipeline. Over recent reporting periods, revenue has moved from A$13.2 million in H2 2024 to A$11.8 million in H1 2025 and A$11.7 million in H2 2025, while basic EPS losses have shifted from A$0.055 in H2 2024 to A$0.0548 in H1 2025 and A$0.046 in H2 2025. This gives investors a...

McMillan Shakespeare (ASX:MMS) H1 2026 Earnings Snapshot McMillan Shakespeare (ASX:MMS) has posted its H1 2026 numbers with revenue of A$297.4 million and basic EPS of A$0.71, against a trailing twelve month backdrop where revenue was A$584.1 million and EPS was A$1.44. Over recent halves, the company has seen revenue move from A$256.5 million and EPS of A$0.63 in H1 2024 to A$264.5 million and A$0.66 in H2 2024, before reaching A$297.4 million and A$0.71 in H1 2025. This sets up a story...

Mayne Pharma Group (ASX:MYX) has released its H1 2026 numbers, posting revenue of A$212.1 million with a basic EPS loss of A$0.15, while trailing 12 month figures show revenue of A$407.1 million and a basic EPS loss of A$1.04. Over recent halves the company has seen revenue sit in the A$195 million to A$213 million range with basic EPS losses between A$0.25 and A$0.89, setting the scene for investors to weigh steady top line scale against ongoing pressure on margins and the path to cleaner...

Lindsay Australia Limited recently reported half-year results for the period ended 31 December 2025, with sales rising to A$534.06 million from A$427.77 million a year earlier, while net income eased to A$12.94 million from A$14.66 million. Despite the stronger top line, the decline in basic earnings per share from A$0.0474 to A$0.0364 highlights that higher revenue has not yet translated into proportionate profit growth. We’ll now examine how this combination of higher revenue but softer...

Half year earnings shift Insignia Financial into profit Insignia Financial (ASX:IFL) has put fresh numbers on the table, with half year earnings to December 31, 2025 showing A$830 million in sales and net income of A$78.8 million after a net loss a year earlier. See our latest analysis for Insignia Financial. At a share price of A$4.66, Insignia Financial has seen a 2.87% 90 day share price return and a 6.39% 1 year total shareholder return. This suggests momentum has been steady rather than...

Fresh from its H1 2026 report, Bellevue Gold (ASX:BGL) posted trailing twelve month revenue of A$441.4 million and a basic EPS loss of A$0.04, with net income excluding extra items at a loss of A$55.3 million. The company has seen revenue move from A$249.3 million in H2 2024 to A$222.3 million in H1 2025 and A$172.6 million in H2 2025, while basic EPS shifted from A$0.06 in H2 2024 to A$0.01 in H1 2025 before slipping to a loss of A$0.04 in H2 2025. For investors, that combination of a solid...

Greatland Resources (ASX:GGP) has just reported its H1 2026 numbers, with trailing 12 month revenue sitting at about A$1.9b and net income at around A$644m, while the current share price is A$13.83. Over recent periods the company has seen revenue move from A$0 in H2 2024 to about A$940.0m in H2 2025, alongside basic EPS shifting from a loss of A$0.071537 per share in H2 2024 to A$0.45805 per share in H2 2025. With a reported net profit margin of 33.6% and very strong recent earnings growth...

Why IPH (ASX:IPH) is back on investors’ radar IPH (ASX:IPH) has drawn fresh attention after its half year 2025 earnings update showed higher revenue and net income compared with the prior period, followed closely by a new on market share buyback announcement. See our latest analysis for IPH. IPH’s latest earnings and the fresh buyback plan have arrived after a choppy period, with a 7 day share price return of 7.9% following shorter term weakness, while the 1 year total shareholder return of...

Hearts and Minds Investments (ASX:HM1) has posted its H1 2026 numbers with trailing twelve month revenue of A$43.3 million and basic EPS of A$0.08, while the latest reported half year in H2 2025 showed revenue of A$28.1 million and basic EPS of A$0.06. This keeps the focus firmly on how much profit it is converting from its investment portfolio. Over recent reporting periods the company has seen revenue move from A$57.7 million in H2 2024 to A$133.6 million in H1 2025 and A$28.1 million in H2...

Austco Healthcare (ASX:AHC) has reported a solid set of H1 2026 numbers, with revenue of A$48.2 million and net income of A$4.7 million translating to basic EPS of A$0.0128 as the company updates the market on its latest half year. Over the past three reported halves, revenue has moved from A$36.9 million in H1 2025 to A$44.5 million in H2 2025 and now A$48.2 million, while basic EPS has shifted from A$0.0081 to A$0.0082 and now A$0.0128. Together, these figures give investors clearer...

When companies post strong earnings, the stock generally performs well, just like Viva Leisure Limited's ( ASX:VVA...

As the Australian market navigates a busy reporting season, bolstered by gains in tech stocks and fluctuating commodity prices, investors are keenly watching the ASX for signs of stability and growth. In this environment, identifying stocks with strong fundamentals becomes crucial, as they offer resilience amid economic shifts and sector-specific developments.

nib holdings has recently announced adjustments to its 2026 health insurance premiums across Australian Residents Health Insurance and other segments, reflecting updated regulatory and market conditions. Because premiums are a core revenue lever, these changes may influence nib’s balance between growth, affordability, and claims cost control across its portfolio. We’ll now examine how these 2026 premium adjustments may affect nib holdings’ investment narrative, particularly around revenue...